Raynauds Disease (Cardiovascular) - Drugs in Development, 2021
Summary Raynauds Disease (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Raynauds Disease pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Raynauds Disease, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Raynauds Disease and features dormant and discontinued projects.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: * This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase. * Certain sections in the report may be removed or altered based on the availability and relevance of data.
Scope - The report provides a snapshot of the Global Therapeutic Landscape of Raynauds Disease (Cardiovascular). - The report reviews pipeline therapeutics for Raynauds Disease (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources. - The report covers pipeline products based on various stages of development ranging from discovery till pre-registration. - The report features descriptive drug profiles for the pipeline products which includes, Product Description, Descriptive MoA, R&D Brief, Licensing and Collaboration details & Other Developmental Activities. - The report reviews key players involved in the development of Raynauds Disease (Cardiovascular) therapeutics and enlists all their major and minor projects. - The report assesses Raynauds Disease (Cardiovascular) therapeutics based on Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. - The report summarizes all the dormant and discontinued pipeline projects. - The report reviews latest news related to pipeline therapeutics for Raynauds Disease (Cardiovascular).
Reasons to Buy - Gain strategically significant competitor information, analysis, and insights to formulate effective Research and Development (R&D) strategies. - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. - Identify and understand important and diverse types of therapeutics under development for Raynauds Disease (Cardiovascular). - Identify potential new clients or partners in the target demographic. - Develop strategic initiatives by understanding the focus areas of leading companies. - Plan Mergers and Acquisitions (M&A) effectively by identifying key players and it’s most promising pipeline therapeutics. - Devise corrective measures for pipeline projects by understanding Raynauds Disease (Cardiovascular) pipeline depth and focus of Indication therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.
Our reports have been used by over 10K customers, including:
The ablation technology market is projected to reach USD 8.1 Billion by 2026 from USD 5.2 Billion in 2021, at a CAGR of 9.3% during the forecast period. The growing elderly population has also driven the incidence of target conditions and contributed to the demand for effective treatment. However, the reuse and reprocessing of devices in developed...
The analyst presents post–COVID-19 growth opportunities and strategic imperatives for the global decentralized clinical trials (DCT) market, covering the market’s maturity, key participants, adoption drivers and restraints, and recent mergers and acquisitions. The report identifies initiatives by major global contract research organizations...
The global hemodialysis market reached a value of US$ 80 Billion in 2020. Looking forward, the analyst expects the market to grow at a CAGR of 4.8% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic...
The global aesthetic lasers and energy devices market reached a value of US$ 4,172 Million in 2020. Looking forward, the analyst expects the market to grow at a CAGR of 10.2% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect...
175 pages •
By The Business Research Company
• May 2021
Major players in the fertility services market are Merck KGaA, Care Fertility, INVO Bioscience, Vitrolife, Monash IVF Group, Carolinas Fertility Institute, IntegraMed, Inc., New Hope Fertility Center, and Apollo Hospitals Enterprise Ltd. The global fertility services market is expected to grow from $16.948 billion in 2020 to $18.475...
Global Genetic Genealogy Market, By Test Type (DNA Profiling v/s DNA Testing), By Application (Direct Maternal Lineages, Direct Paternal Lineages, Ancestral Origins, Law Enforcement, Others), By End User (Direct-to-Consumer Testing Companies, Research Institutes & Academic Organizations, Others), By Region, Company Forecast & Opportunities,...
Surgical Snares Market Size, Share & Trends Analysis Report By Usability (Single-use, Reusable), By Application (GI Endoscope, Arthroscopy), By End Use (Hospitals, ASCs), By Region, And Segment Forecasts, 2021 - 2028
Surgical Snares Market Growth & Trends
The global surgical snares market...
With 99% of healthcare organizations in some stage of digital transformation, it’s clear that stakeholders understand the value of IT solutions.Digital health solutions offer great promise for new care delivery models, expanded access, better patient outcomes, and improved operational efficiency.
Advanced technologies can help them...
Chronic Disease Prevalence
Health Provider Density
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.